RxDoctor Payments Data

Jennifer Wilson, DO

Family Medicine · Chandler, TXNPI 1477639219

Payments from drug & device makers

$377in general payments, 2019–2025

Across 22 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$142
  • GSK$52
  • AbbVie$39
  • Exact Sciences$33
  • Lilly USA, LLC$28
  • Neurocrine Biosciences, Inc.$21
  • plus $61 from 4 others

What the payments were for

  • Food & beverage$377100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$377 in reported general payments places this provider in the 45th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$93,287
Medicare patients
399
Services billed
1,249

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin210$161,974
OzempicSemaglutide113$137,641
EliquisApixaban271$101,563
MounjaroTirzepatide89$98,235
Trelegy ElliptaFluticasone/Umeclidin/Vilanter75$57,656
MyrbetriqMirabegron93$32,545
GlatopaGlatiramer Acetate11$30,557
XareltoRivaroxaban78$26,648
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog85$25,150
Breo ElliptaFluticasone/Vilanterol37$22,180
JanuviaSitagliptin Phosphate25$15,650
Fiasp FlextouchInsulin Aspart (Niacinamide)21$15,136
Combivent RespimatIpratropium/Albuterol Sulfate19$13,386
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen415$12,977
Gabapentin654$12,734

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$142$137,641113 claims
Lilly USA, LLCMounjaro$28$98,23589 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$52$89,150129 claims
MerckJanuvia$18$15,65025 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Chandler

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →